Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anaphylaxis is a severe and life-threatening complication during the perioperative period. Perioperative anaphylaxis is still associated with a significant mortality despite quick and efficient management using epinephrine, the mainstay of acute treatment. Experimental data and few case reports are suggesting that hemostasis, and more precisely platelets, could play a role in anaphylaxis. Our main hypothesis is that activation of the hemostatic system contributes to the severity of the reaction
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Platelet activation | Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count | As soon as possible after onset of anaphylaxis |
| Platelet activation | Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count | 1-2 hours after the onset of anaphylaxis |
| Platelet activation | Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count | 24 hours after the onset of anaphylaxis |
| Platelet activation | Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count | During the allergic workup (4-6 weeks after) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study will focus on any adult patient with a suspected diagnosis of perioperative anaphylactic shock
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Charles-Ambroise TACQUARD, PHD | Contact | +333 69 55 16 08 | charlesambroise.tacquard@chru-strasbourg.fr | |
| Xavier DELABRANCHE, PHD | Contact | 03.69.55.09.36 | Xavier.delabranche@chru-strasbourg.fr |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006469 | Hemoptysis |
| D000707 | Anaphylaxis |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |